Related Experiment Video
Updated: May 9, 2025
09:44
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
2.9K
Interface between reproductive and metabolic dysfunction in polycystic ovary syndrome
Melody A Rasouli1, Jessica Katz, Daniel A Dumesic
1Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Current Opinion in Obstetrics & Gynecology
|April 29, 2025
Summary
Polycystic ovary syndrome (PCOS) arises from complex interactions between hyperandrogenism and hyperinsulinemia. Understanding these links is crucial for managing metabolic diseases and improving health outcomes in women with PCOS.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Metabolic Health
Background:
- Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism and hyperinsulinemia.
- The precise causal links between these conditions in PCOS pathogenesis remain incompletely understood.
Purpose of the Study:
- To examine the specific causal relationships between hyperandrogenism and hyperinsulinemia in the context of systemic insulin resistance.
- To elucidate how these complex interactions contribute to the phenotypic expression of PCOS.
Main Methods:
- Review of clinical interventions for treating hyperandrogenism and hyperinsulinemia in PCOS.
- Examination of in-vitro studies on androgen and insulin actions in relevant target tissues.
Main Results:
- Androgen-insulin interrelationships are identified as central to the origins of PCOS.
- Evidence suggests these interactions are critical for understanding PCOS development.
Conclusions:
- Bidirectional interactions between hyperandrogenism and hyperinsulinemia may represent an ancient adaptation for survival during famine.
- In modern environments, these interactions predispose PCOS women to metabolic diseases and pregnancy complications.
- Improved preventive healthcare is essential for optimizing the long-term health of women with PCOS and their offspring.
Related Concept Videos
02:07Oogenesis
63.1K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.1K
01:30Hormonal Control of the Ovarian Cycle
311
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
311
01:22Hormonal Regulation of the Menstrual Cycle
183
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
183
01:27Ovarian Cycle
692
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
692
01:29The Endocrine System
164
The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that...
164
01:28Infertility in Females
184
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
184